ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adolescent Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,511Medicare Part D Prescriptions Filled, Including Refills
$734K Total Retail Price of All Prescriptions
580 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LISINOPRIL 483 433
FUROSEMIDE 430 405
SIMVASTATIN 379 354
SERTRALINE HCL 336 294
OMEPRAZOLE 307 266
WARFARIN SODIUM 291 269
METOPROLOL TARTRATE 281 246
ATORVASTATIN CALCIUM 263 237
AMLODIPINE BESYLATE 244 232
HYDROCHLOROTHIAZIDE 235 220
TRAMADOL HCL 228 182
ATENOLOL 212 195
METOPROLOL SUCCINATE 203 198
PREDNISONE 192 188
LOSARTAN POTASSIUM 167 167
ALENDRONATE SODIUM 158 139
LEVOTHYROXINE SODIUM 156 148
GABAPENTIN 144 135
LANTUS 138 100
METFORMIN HCL 137 110
HYDROCODONE-ACETAMINOPHEN 114 87 S3
SPIRIVA 112 104
DIOVAN 110 101
PROAIR HFA 102 94
INSULIN SYRINGE 96 64
SPIRONOLACTONE 94 79
VENTOLIN HFA 93 55
ALLOPURINOL 92 81
LOVASTATIN 86 75
ADVAIR DISKUS 82 76
NAMENDA 79 79
GLYBURIDE 78 71 R
TRIAMCINOLONE ACETONIDE 75 72
VENLAFAXINE HCL ER 69 68
LIPITOR 63 56
CIPROFLOXACIN HCL 63 57
OXYCODONE HCL 63 42 S2
PANTOPRAZOLE SODIUM 62 61
FLOVENT HFA 58 52
TAMSULOSIN HCL 56 56
MECLIZINE HCL 54 53
NOVOLOG 52 28
PRIMIDONE 51 34
TRAZODONE HCL 51 39
FLUOXETINE HCL 51 35
CYCLOBENZAPRINE HCL 50 13 R
NITROSTAT 50 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.